Hematology
1439 articles · 38 journals
Journals in this subcategory (38)
- Annals of Thoracic Surgery Short Reports · Elsevier (94)
- Blood Advances · Elsevier (94)
- Journal of Thrombosis and Haemostasis · Elsevier (90)
- Research and Practice in Thrombosis and Haemostasis · Elsevier (84)
- Thrombosis Research · Elsevier (80)
- British Journal of Haematology · Wiley (75)
- European Journal of Haematology · Wiley (74)
- Clinical Lymphoma, Myeloma & Leukemia · Elsevier (71)
- Blood · Elsevier (70)
- Transfusion and Apheresis Science · Elsevier (69)
- Radiotherapy & Oncology · Elsevier (66)
- Vox Sanguinis · Wiley (65)
- Annals of Oncology · Elsevier (64)
- American Journal of Hematology · Wiley (58)
- Haemophilia · Wiley (58)
- Hematology/Oncology Clinics of North America · Elsevier (50)
- Transfusion · Wiley (49)
- Transfusion Medicine Reviews · Elsevier (39)
- Seminars in Hematology · Elsevier (37)
- The Lancet Haematology · Elsevier (28)
- Seminars in Oncology · Elsevier (27)
- Experimental Hematology · Elsevier (22)
- HemaSphere · Wiley (17)
- Thrombosis Update · Elsevier (15)
- Transfusion Medicine · Wiley (13)
- Journal of Clinical Apheresis · Wiley (12)
- Blood Cancer Journal · Springer Nature (7)
- Leukemia · Springer Nature (7)
- Ca-A Cancer Journal for Clinicians · Wiley (4)
- Annals of Hematology · Springer Nature (0)
- Blood Research · Springer Nature (0)
- Experimental Hematology & Oncology · Springer Nature (0)
- Indian Journal of Hematology and Blood Transfusion · Springer Nature (0)
- International Journal of Clinical Oncology · Springer Nature (0)
- International Journal of Hematology · Springer Nature (0)
- Medical Oncology · Springer Nature (0)
- Thrombosis Journal · Springer Nature (0)
- memo - Magazine of European Medical Oncology · Springer Nature (0)
-
Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML
Leukemia, Published online: 11 November 2026; doi:10.1038/s41375-026-03173-0 Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML
-
Orelabrutinib plus R‐CHOP in patients with newly diagnosed non‐GCB double‐expressor DLBCL: A single‐arm, phase II study
Summary Double‐expressor diffuse large B‐cell lymphoma (DE‐DLBCL) patients, defined by co‐expression of MYC proto‐oncogene protein (≥40%) and B‐cell lymphoma 2 protein (≥50%), typically have poor outcomes with the traditional first‐line...
- Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ALL) and lymphoblastic lymphoma (T‐LBL)
- Sustained disease remission with reduced‐intensity allogeneic hematopoietic cell transplant for VEXAS syndrome
-
Development of a novel manufacturing process for highly purified and stable immunoglobulin M with enhanced plasma utilization
Abstract Background and Objectives Immunoglobulin M (IgM) is a promising therapeutic agent. However, its production is limited by high molecular weight, complex structure and poor stability. This study aimed to develop a novel...
- Collection efficiency of hematopoietic cells by apheresis after mobilization in a single centre: Analysis of the last 15 years
- Why donors intend to return: Motivation, satisfaction and post‐donation intention in a high‐demand tertiary hospital setting in Lagos, Nigeria
- Compensated iron depletion in repeated blood donations: Stability of circulating microRNAs despite reduced ferritin stores
- Transforming thalassaemia care in India through virtual capacity building: Evolution of a national training initiative using extension for community healthcare outcomes model
- Opportunities for vein‐to‐vein datasets from a blood establishment perspective: Towards a ‘Pan‐European Transfusion Research InfrAstructure’
- Hepatitis E virus seroepidemiology among Malaysian blood donors: Prevalence and associated risk factors
- Mapping syphilis surveillance: Insights into blood donation screening practices worldwide
- Comparing the volume of umbilical cord blood collection using different techniques
- HIV incidence and correlates of incident infection among Brazilian blood donors following adoption of individual donor assessment
- Design, development and implementation of a new transfusion safety system at the Banc de Sang i Teixits in Catalonia (Spain)
- Evaluation of the in vitro quality of X‐ray irradiated red cell concentrates processed and stored using di(2‐ethylhexyl) terephthalate plasticized blood bag sets
- Exploring intraoperative autotransfusion in a blood desert: A single‐centre study in Turkana County, Kenya
- Identification of a novel high‐prevalence red blood cell antigen on junctional adhesion molecule‐A defines a new blood group system
- Identification of thrombotic complications of the arm in blood donors: Evidence from literature and national data
- Public perspectives on potential changes to malaria deferral criteria in Canada
- Evaluation of data from the hPSCreg®, a global registry for human pluripotent stem cell lines (hPSC‐lines)
- Prevalence, incidence and residual risk of HBV, HCV and HIV in Turkish Red Crescent blood donors: A 9‐year survey initiated with the implementation of nucleic acid testing (2015–2023)
- Beyond universal mitigation: Risk‐stratified approaches for preventing vasovagal reactions in blood donors
- Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’
- Response to ‘Beyond universal mitigation: Risk‐stratified approaches for preventing vasovagal reactions in blood donors’
- Response to: Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’
- Discordant prenatal and postnatal RhD typing caused by a novel RHD frameshift variant (c.540del; p.Leu181CysfsTer48) in Swedish individuals
- Voluntary non‐remunerated plasma collection in Denmark: Experiences from the Central Denmark Region
- Risk of vasovagal reactions among trans versus cisgender whole blood donors
- MicroRNA profiles as quality biomarkers in stored blood components: A narrative review